Efficacy of lanadelumab at fixed and modified dosing regimens in patients aged 2 to <12 years old with hereditary angioedema (HAE) in the phase 3, open-label, multicenter SPRING Study
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY（2023）
关键词
hereditary angioedema,lanadelumab,dosing regimens,open-label
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要